117
Participants
Start Date
July 24, 2018
Primary Completion Date
December 15, 2025
Study Completion Date
September 15, 2026
Acetylsalicylic acid
81 mg PO daily or 325 mg PO daily
Placebo
One tablet PO daily
Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Westmead
Peter McCallum Cancer Institute, Melbourne
King Edward Memorial Hospital, Subiaco
St John of God Subiaco, Subiaco
Tom Baker Cancer Centre, Calgary
Clinical Research Unit at Vancouver Coastal, Vancouver
CancerCare Manitoba, Winnipeg
Dr. H. Bliss Murphy Cancer Centre, St. John's
Kingston Health Sciences Centre, Kingston
North York General Hospital, Toronto
Women's College Hospital, Toronto
CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal
Hotel-Dieu de Quebec, Québec
CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke
Collaborators (1)
Apotex Inc.
INDUSTRY
Canadian Cancer Trials Group
NETWORK